HI
HAE icon

HBK Investments’s Haemonetics HAE Stock Holding History

HBK Investments’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-10,100
Closed -$906K – 1243
2018
Q2 		$906K Buy
+10,100
New +$853K 0.01% 663
2018
Q1 		– Sell
-19,503
Closed -$1.13M – 1030
2017
Q4 		$1.13M Buy
19,503
+15,012
+334% +$790K 0.01% 581
2017
Q3 		$202K Buy
+4,491
New +$187K ﹤0.01% 966
2017
Q2 		– Sell
-6,080
Closed -$247K – 954
2017
Q1 		$247K Buy
+6,080
New +$237K ﹤0.01% 609

Other funds holding HAE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

HBK Investments's HAE Position: Q3 2018 in Review

HBK Investments sold out of Haemonetics (HAE) in Q3 2018, closing a stake of 10,100 shares — an estimated $906K sold.

HBK Investments first reported a position in HAE in Q1 2017 and held it in 4 quarters. The position peaked at $1.13M in Q4 2017. 292 funds tracked by Wall St. Rank hold HAE as of Q3 2018.

  • HBK Investments reported no remaining Haemonetics position as of Q3 2018 after selling out during the quarter.
  • HBK Investments sold 10,100 Haemonetics shares in Q3 2018, an estimated $906K.
  • HBK Investments first reported a position in Haemonetics in Q1 2017 and held it in 4 quarters.
  • HBK Investments's Haemonetics position peaked at $1.13M in Q4 2017.
  • 292 funds tracked by Wall St. Rank held Haemonetics as of Q3 2018.

Based on HBK Investments's 13F filing for Q3 2018, filed 14 Nov 2018.